PT-141 Pen

PT-141 (Bremelanotide) is a synthetic peptide analogue of alpha-melanocyte-stimulating hormone (α-MSH). It is commonly utilised in laboratory research involving melanocortin receptor interactions, particularly MC3R and MC4R, and associated peptide signalling pathways.

PT-141 is a synthetic peptide studied in controlled research environments as a model compound in investigations involving melanocortin receptor systems, peptide structure, and signalling pathway analysis.

Chemical reference information: CAS number: 189691-06-3; Molecular formula: C₅₀H₆₈N₁₄O₁₀; Molecular weight: 1025.2 g/mol; Sequence: Ac-Nle-cyclo(Asp-His-D-Phe-Arg-Trp-Lys)-OH. These reference identifiers describe the formulation; the batch-specific analytical record identifies the supplied material.

Reference conditions for unreconstituted research material are −20°C with moisture and direct light excluded. Use the storage instructions on the supplied batch record for the actual presentation, and record any change of physical state or storage conditions.

Where laboratory preparation is required, use an appropriate validated solvent and aseptic peptide-handling procedure. Solvent compatibility, final concentration, and post-preparation storage depend on the specific formulation and experimental protocol. The catalog strength is the compound amount, not the concentration of a prepared solution.

NORVEXA Bioscience batch documentation can be requested using the printed reference and lot number. Review identity, analytical purity, presentation, and handling specifications before including a material in a laboratory workflow.

PT-141 10 mg is offered as a NORVEXA research pen. The selected strength refers to the compound content of this pen reference. Request the matching batch record for identity, analytical specifications, and presentation details.

Reference conditions for unreconstituted research material are −20°C with moisture and direct light excluded. Use the storage instructions on the supplied batch record for the actual presentation, and record any change of physical state or storage conditions.

Where laboratory preparation is required, use an appropriate validated solvent and aseptic peptide-handling procedure. Solvent compatibility, final concentration, and post-preparation storage depend on the specific formulation and experimental protocol. The catalog strength is the compound amount, not the concentration of a prepared solution.

NORVEXA Bioscience batch documentation can be requested using the printed reference and lot number. Review identity, analytical purity, presentation, and handling specifications before including a material in a laboratory workflow.

CAS number

189691-06-3

Molecular formula

C₅₀H₆₈N₁₄O₁₀

Molecular weight

1025.2 g/mol

Sequence

Ac-Nle-cyclo(Asp-His-D-Phe-Arg-Trp-Lys)-OH

Include the printed batch reference when requesting your certificate of analysis. The record applies to the batch supplied to your laboratory.